Bruker (BRKR) Long-Term Debt Repayments (2010 - 2026)
Bruker (BRKR) posted Long-Term Debt Repayments of $181.3 million for Q1 2026, up 24.86% on a QoQ basis from $145.2 million in Q4 2025, and up 2254.55% year-over-year from $7.7 million in Q1 2025.
Bruker (BRKR) Long-Term Debt Repayments (2010 - 2026) Analysis & Trends
Bruker's Long-Term Debt Repayments history runs 10 years deep, the most recent figure standing at $181.3 million for Q1 2026.
- Quarterly Long-Term Debt Repayments rose 2254.55% year-over-year to $181.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $378.7 million (up 954.87% YoY) and the FY2025 annual result came in at $466.5 million, up 244.53% from the prior year.
- Long-Term Debt Repayments was $181.3 million for Q1 2026 at Bruker, up from $145.2 million in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at $181.3 million in Q1 2026 and bottomed at $2.1 million in Q1 2023.
- A 4-year average of $52.4 million and a median of $12.7 million in 2024 frame the typical range for Long-Term Debt Repayments.
- Annual changes were most pronounced in 2024 — Long-Term Debt Repayments jumped 5004.76% — and 2025, when it sank 92.82%.
- Bruker's Long-Term Debt Repayments stood at $2.1 million in 2023, then soared by 261.9% to $7.6 million in 2024, then surged by 1810.53% to $145.2 million in 2025, then gained by 24.86% to $181.3 million in 2026.
- Business Quant data shows BRKR's Long-Term Debt Repayments at $181.3 million in Q1 2026, $145.2 million in Q4 2025, and $37.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.42 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.00 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -64.39 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bruker | 9.46 Bn | 9.50 Bn | 379.80 Mn | 181.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 181.30 Mn |
| Mar 31, 2026 | 181.30 Mn |
| Dec 31, 2025 | 145.20 Mn |
| Dec 31, 2025 | 145.20 Mn |
| Sep 30, 2025 | 37.60 Mn |
| Sep 30, 2025 | 37.60 Mn |
| Jun 30, 2025 | 14.60 Mn |
| Jun 30, 2025 | 14.60 Mn |
| Mar 31, 2025 | 7.70 Mn |
| Mar 31, 2025 | 7.70 Mn |
| Dec 31, 2024 | 7.60 Mn |
| Dec 31, 2024 | 7.60 Mn |
| Sep 30, 2024 | 9.80 Mn |
| Sep 30, 2024 | 9.80 Mn |
| Jun 30, 2024 | 10.80 Mn |
| Jun 30, 2024 | 10.80 Mn |
| Mar 31, 2024 | 107.20 Mn |
| Mar 31, 2024 | 107.20 Mn |
| Mar 31, 2023 | 2.10 Mn |
| Mar 31, 2023 | 2.10 Mn |